BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 32745379)

  • 1. Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma.
    Schrecker C; Schulze F; Trojan J; Bechstein WO; Zeuzem S; Koch C
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):187. PubMed ID: 38602548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significances of several fibrotic markers for prognosis in hepatocellular carcinoma patients who underwent hepatectomy.
    Nanashima A; Hiyoshi M; Imamura N; Hamada T; Tsuchimochi Y; Shimizu I; Ochiai T; Nagata K; Hasuike S; Nakamura K; Iwakiri H; Kawakami H
    Transl Cancer Res; 2024 May; 13(5):2332-2345. PubMed ID: 38881924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostication algorithm for non-cirrhotic non-B non-C hepatocellular carcinoma-a multicenter study under the aegis of the French Association of Hepato-Biliary Surgery and liver Transplantation.
    Maulat C; Truant S; Hobeika C; Barbier L; Herrero A; Doussot A; Gagnière J; Girard É; Tranchart H; Regimbeau JM; Fuks D; Cauchy F; Prodeau M; Notte A; Toubert C; Salamé E; El Amrani M; Andrieu S; Muscari F; Shourick J; Suc B
    Hepatobiliary Surg Nutr; 2023 Apr; 12(2):192-204. PubMed ID: 37124677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What should be the best approach post-liver resection in non-viral non-cirrhotic hepatocellular carcinoma?
    Machado MV
    Hepatobiliary Surg Nutr; 2024 Jun; 13(3):554-556. PubMed ID: 38911205
    [No Abstract]   [Full Text] [Related]  

  • 5. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
    Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
    Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection.
    Nishikawa H; Osaki Y; Komekado H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
    Oncol Rep; 2015 Jan; 33(1):88-94. PubMed ID: 25354477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
    Jin J; Zhu P; Liao Y; Li J; Liao W; He S
    Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.
    Yeh CN; Chen MF; Lee WC; Jeng LB
    J Surg Oncol; 2002 Dec; 81(4):195-202. PubMed ID: 12451624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value and non-invasive predictors of splenomegaly in cirrhotic patients with hepatocellular carcinoma following curative resection.
    Zhou L; Wang SB; Chen SG; Qu Q; Rui JA
    Adv Clin Exp Med; 2020 Jul; 29(7):879-886. PubMed ID: 32745379
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.